| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
22,526 |
20,958 |
$4.77M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
21,373 |
20,387 |
$3.40M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,238 |
9,701 |
$2.64M |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
22,290 |
5,561 |
$2.20M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,216 |
3,122 |
$1.14M |
| D2934 |
|
8,767 |
3,027 |
$1.01M |
| D3220 |
Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction |
7,350 |
2,922 |
$905K |
| D7140 |
Extraction, erupted tooth or exposed root |
4,835 |
2,239 |
$635K |
| D1206 |
Topical application of fluoride varnish |
2,738 |
2,714 |
$587K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
9,023 |
3,202 |
$564K |
| D0272 |
Bitewings - two radiographic images |
2,592 |
2,556 |
$549K |
| D0220 |
Intraoral - periapical first radiographic image |
3,365 |
2,273 |
$542K |
| D3310 |
|
4,371 |
1,515 |
$531K |
| D1120 |
Prophylaxis - child |
2,402 |
2,379 |
$513K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
720 |
711 |
$501K |
| 80053 |
Comprehensive metabolic panel |
18,952 |
16,819 |
$492K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
5,953 |
5,810 |
$459K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,813 |
10,938 |
$416K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,241 |
7,270 |
$411K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,338 |
1,317 |
$393K |
| 95811 |
|
583 |
573 |
$389K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,905 |
6,971 |
$385K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,233 |
4,600 |
$376K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,090 |
2,018 |
$375K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
2,036 |
1,211 |
$310K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,392 |
3,319 |
$302K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
782 |
771 |
$287K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,411 |
18,792 |
$282K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,030 |
999 |
$270K |
| D0230 |
Intraoral - periapical each additional radiographic image |
1,386 |
1,061 |
$203K |
| D2330 |
|
1,214 |
706 |
$198K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,495 |
2,444 |
$188K |
| 71046 |
Radiologic examination, chest; 2 views |
3,578 |
3,426 |
$185K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,640 |
1,542 |
$181K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,297 |
4,867 |
$171K |
| G0378 |
Hospital observation service, per hour |
405 |
362 |
$168K |
| 87631 |
|
1,836 |
1,760 |
$168K |
| 71045 |
Radiologic examination, chest; single view |
4,092 |
3,877 |
$154K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,974 |
1,788 |
$138K |
| 84703 |
|
7,475 |
7,079 |
$133K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,416 |
1,365 |
$131K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,213 |
1,200 |
$128K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,093 |
1,090 |
$123K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,555 |
1,529 |
$121K |
| 83690 |
|
6,988 |
6,449 |
$112K |
| D1351 |
Sealant - per tooth |
879 |
372 |
$106K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,948 |
5,634 |
$106K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
266 |
260 |
$100K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
306 |
303 |
$98K |
| 36415 |
Collection of venous blood by venipuncture |
23,435 |
20,490 |
$97K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
931 |
763 |
$95K |
| 76830 |
Ultrasound, transvaginal |
933 |
918 |
$90K |
| 81001 |
|
10,831 |
10,114 |
$88K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
974 |
941 |
$88K |
| 84484 |
|
4,797 |
3,834 |
$79K |
| D0240 |
|
393 |
301 |
$78K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,011 |
2,949 |
$74K |
| 73562 |
|
959 |
906 |
$71K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,242 |
1,204 |
$70K |
| 73610 |
|
885 |
848 |
$69K |
| 73030 |
|
877 |
794 |
$65K |
| 73630 |
|
1,004 |
954 |
$64K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,049 |
647 |
$61K |
| 87040 |
|
1,862 |
1,064 |
$60K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,015 |
1,012 |
$59K |
| 73130 |
|
988 |
918 |
$57K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,552 |
2,321 |
$56K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
38 |
38 |
$52K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,320 |
4,170 |
$51K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
9,564 |
9,125 |
$51K |
| 59025 |
Fetal non-stress test |
490 |
397 |
$49K |
| 83605 |
|
2,009 |
1,640 |
$49K |
| 96376 |
|
1,746 |
1,352 |
$47K |
| D2331 |
|
166 |
150 |
$43K |
| 93976 |
|
410 |
403 |
$42K |
| 83735 |
|
3,571 |
2,832 |
$41K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
523 |
507 |
$40K |
| D1510 |
|
180 |
150 |
$36K |
| 73110 |
|
573 |
531 |
$34K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
197 |
138 |
$34K |
| J2704 |
Injection, propofol, 10 mg |
6,372 |
6,202 |
$32K |
| 82962 |
|
3,356 |
2,158 |
$31K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,515 |
4,885 |
$31K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
661 |
653 |
$30K |
| 94760 |
|
1,530 |
1,275 |
$29K |
| 84702 |
|
1,095 |
984 |
$26K |
| D9971 |
|
186 |
97 |
$23K |
| 97161 |
|
483 |
475 |
$22K |
| 87634 |
|
502 |
495 |
$21K |
| 74018 |
|
362 |
351 |
$20K |
| 43235 |
|
57 |
57 |
$19K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
541 |
528 |
$19K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
541 |
528 |
$19K |
| 84443 |
Thyroid stimulating hormone (TSH) |
883 |
854 |
$18K |
| 87186 |
|
1,011 |
941 |
$17K |
| 87077 |
|
1,383 |
1,288 |
$17K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
20 |
12 |
$17K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
86 |
86 |
$17K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
743 |
355 |
$16K |
| 85379 |
|
925 |
884 |
$15K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
83 |
83 |
$14K |
| 81003 |
|
3,812 |
3,679 |
$14K |
| 83880 |
|
463 |
428 |
$14K |
| 76801 |
|
151 |
136 |
$13K |
| 76536 |
|
132 |
128 |
$13K |
| 93971 |
|
152 |
148 |
$13K |
| 85610 |
|
1,390 |
1,269 |
$13K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
42 |
41 |
$12K |
| 94664 |
|
135 |
132 |
$12K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,818 |
7,284 |
$11K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
115 |
90 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
470 |
455 |
$11K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,405 |
6,178 |
$11K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
103 |
103 |
$10K |
| 87632 |
|
54 |
43 |
$10K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,400 |
5,310 |
$9K |
| 97162 |
|
134 |
131 |
$8K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
191 |
91 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
370 |
358 |
$7K |
| 87650 |
|
280 |
274 |
$7K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
26 |
26 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
126 |
115 |
$7K |
| 72100 |
|
84 |
82 |
$6K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
15 |
15 |
$6K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,521 |
3,017 |
$6K |
| D2929 |
|
14 |
14 |
$5K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
14 |
14 |
$5K |
| 74022 |
|
72 |
71 |
$5K |
| 81025 |
|
589 |
582 |
$4K |
| 86900 |
|
580 |
540 |
$4K |
| D1208 |
Topical application of fluoride, excluding varnish |
17 |
17 |
$4K |
| 86901 |
|
580 |
540 |
$3K |
| 90715 |
|
230 |
225 |
$3K |
| 86850 |
|
211 |
197 |
$3K |
| 85730 |
|
289 |
268 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
13 |
13 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
42 |
39 |
$2K |
| 73080 |
|
35 |
34 |
$2K |
| D3330 |
Endodontic therapy, molar tooth (excluding final restoration) |
25 |
13 |
$2K |
| 85027 |
|
282 |
252 |
$2K |
| 82553 |
|
166 |
145 |
$2K |
| 72040 |
|
28 |
28 |
$2K |
| 84100 |
|
183 |
124 |
$2K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
28 |
27 |
$2K |
| D3240 |
|
39 |
14 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
14 |
12 |
$2K |
| D3230 |
|
39 |
14 |
$2K |
| 76770 |
|
27 |
26 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
163 |
158 |
$2K |
| 81002 |
|
637 |
496 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,170 |
1,136 |
$2K |
| 29125 |
|
12 |
12 |
$2K |
| 94761 |
|
73 |
53 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,052 |
978 |
$1K |
| 82550 |
|
165 |
147 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,109 |
951 |
$1K |
| 10060 |
|
15 |
15 |
$1K |
| 74220 |
|
12 |
12 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
311 |
190 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
723 |
578 |
$1K |
| 73502 |
|
31 |
29 |
$1K |
| 80050 |
General health panel |
15 |
14 |
$1K |
| 12001 |
|
12 |
12 |
$1K |
| 76942 |
|
13 |
12 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
106 |
102 |
$1K |
| 80143 |
|
90 |
83 |
$1K |
| 82150 |
|
82 |
81 |
$1K |
| 80179 |
|
87 |
80 |
$1K |
| 85007 |
|
212 |
195 |
$1K |
| 86140 |
|
126 |
119 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
810 |
764 |
$1K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
424 |
406 |
$948.88 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
150 |
148 |
$881.07 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
272 |
269 |
$869.50 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
527 |
458 |
$833.86 |
| 87210 |
|
79 |
79 |
$805.79 |
| 84439 |
|
52 |
51 |
$786.36 |
| A4615 |
Cannula, nasal |
2,309 |
2,271 |
$752.37 |
| 80061 |
Lipid panel |
54 |
51 |
$752.24 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
188 |
133 |
$693.31 |
| 88342 |
|
12 |
12 |
$675.07 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
486 |
430 |
$669.49 |
| 73140 |
|
13 |
12 |
$645.53 |
| 97165 |
|
13 |
13 |
$604.46 |
| 80076 |
|
31 |
29 |
$599.44 |
| J2060 |
Injection, lorazepam, 2 mg |
375 |
335 |
$585.65 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
255 |
255 |
$490.46 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
84 |
82 |
$464.91 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
114 |
110 |
$461.79 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
212 |
194 |
$424.32 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
245 |
242 |
$342.43 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
202 |
191 |
$313.77 |
| J1790 |
Injection, droperidol, up to 5 mg |
266 |
247 |
$304.79 |
| 84550 |
|
33 |
31 |
$304.30 |
| 85652 |
|
56 |
55 |
$304.03 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
13 |
13 |
$288.08 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
15 |
15 |
$258.79 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
84 |
83 |
$255.92 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
125 |
125 |
$230.36 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
342 |
331 |
$229.70 |
| A9270 |
Non-covered item or service |
644 |
287 |
$229.28 |
| 87070 |
|
15 |
12 |
$169.54 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
238 |
220 |
$162.37 |
| 83615 |
|
15 |
14 |
$159.11 |
| C9113 |
Injection, pantoprazole sodium, per vial |
124 |
94 |
$158.75 |
| 87081 |
|
27 |
27 |
$157.35 |
| 82565 |
|
15 |
14 |
$153.69 |
| 84156 |
|
14 |
13 |
$134.41 |
| J0687 |
Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg |
85 |
71 |
$113.10 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
155 |
144 |
$111.27 |
| 87205 |
|
15 |
12 |
$81.23 |
| 85651 |
|
12 |
12 |
$75.45 |
| J3480 |
Injection, potassium chloride, per 2 meq |
14 |
12 |
$71.29 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
68 |
60 |
$67.82 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
16 |
16 |
$67.57 |
| 82272 |
|
12 |
12 |
$62.25 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
17 |
12 |
$59.41 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
14 |
14 |
$55.09 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
12 |
12 |
$53.48 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
70 |
55 |
$47.55 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
13 |
$19.28 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
12 |
12 |
$9.32 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
44 |
40 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
43 |
39 |
$0.00 |